Qpex Biopharma

Qpex Biopharma

Biotechnology, W Bernardo Ct, San Diego, , 92127, California, 11440, United States, 11-50 Employees

qpexbio.com

  • twitter
  • LinkedIn

phone no Phone Number: 85********

Who is QPEX BIOPHARMA

Qpex Biopharma, Inc. a Shionogi Group Company, is a resistance-focused infectious disease company on a mission to make both a dramatic and sustainable improvement in patient care. Leverag...

Read More

map
  • 11440 W Bernardo Ct, San Diego, California, 92127, United States Headquarters: 11440 W Bernardo Ct, San Diego, California, 92127, United States
  • 2018 Date Founded: 2018
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from QPEX BIOPHARMA

Qpex Biopharma Org Chart and Mapping

Employees

Jeff Loutit

Chief Medical Officer

David Griffith

Senior Vice President, Non-Clinical and Clinical Development

Nicole Roos

Clinical Research Associate

Elizabeth Morgan

VP, Clinical and Ra?Qa Operations

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Qpex Biopharma

Answer: Qpex Biopharma's headquarters are located at W Bernardo Ct, San Diego, , 92127, California, 11440, United States

Answer: Qpex Biopharma's phone number is 85********

Answer: Qpex Biopharma's official website is https://qpexbio.com

Answer: Qpex Biopharma's revenue is $5 Million to $10 Million

Answer: Qpex Biopharma's SIC: 2834

Answer: Qpex Biopharma's NAICS: 325412

Answer: Qpex Biopharma has 11-50 employees

Answer: Qpex Biopharma is in Biotechnology

Answer: Qpex Biopharma contact info: Phone number: 85******** Website: https://qpexbio.com

Answer: Qpex Biopharma, Inc. a Shionogi Group Company, is a resistance-focused infectious disease company on a mission to make both a dramatic and sustainable improvement in patient care. Leveraging a multi-faceted approach and a deep understanding of drug resistance mechanisms, we are creating novel products and development. strategies that overcome multi-drug resistance. We are advancing a robust portfolio of treatments that will bring innovation to antibiotic development and deliver the right treatments to the right patients in the right settings. During the previous decade, our team brought 4 antibiotic products to regulatory approvals, with an extensive record of working with public- private partnerships, including partnerships with the Biomedical Advanced Research and Development Authority (BARDA) that led to the first approved antimicrobial drug product under that program in 2017. San Diego-based Qpex was launched in 2018 with investments from New Enterprise Associates, Adams Street Partners, LYZZ Capital, Hatteras Venture Partners and Stanford University Daper Fund. In July 2023, Qpex was acquired by Shionogi, Inc and is now a Shionogi Group Company.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access